154 related articles for article (PubMed ID: 12082588)
1. Linkage disequilibrium mapping identifies a 390 kb region associated with CYP2D6 poor drug metabolising activity.
Hosking LK; Boyd PR; Xu CF; Nissum M; Cantone K; Purvis IJ; Khakhar R; Barnes MR; Liberwirth U; Hagen-Mann K; Ehm MG; Riley JH
Pharmacogenomics J; 2002; 2(3):165-75. PubMed ID: 12082588
[TBL] [Abstract][Full Text] [Related]
2. Effects of single SNPs, haplotypes, and whole-genome LD maps on accuracy of association mapping.
Maniatis N; Collins A; Morton NE
Genet Epidemiol; 2007 Apr; 31(3):179-88. PubMed ID: 17285621
[TBL] [Abstract][Full Text] [Related]
3. Multipoint linkage-disequilibrium mapping narrows location interval and identifies mutation heterogeneity.
Morris AP; Whittaker JC; Xu CF; Hosking LK; Balding DJ
Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13442-6. PubMed ID: 14597696
[TBL] [Abstract][Full Text] [Related]
4. The optimal measure of linkage disequilibrium reduces error in association mapping of affection status.
Maniatis N; Morton NE; Gibson J; Xu CF; Hosking LK; Collins A
Hum Mol Genet; 2005 Jan; 14(1):145-53. PubMed ID: 15548543
[TBL] [Abstract][Full Text] [Related]
5. CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure.
Sistonen J; Sajantila A; Lao O; Corander J; Barbujani G; Fuselli S
Pharmacogenet Genomics; 2007 Feb; 17(2):93-101. PubMed ID: 17301689
[TBL] [Abstract][Full Text] [Related]
6. Molecular diversity at the CYP2D6 locus in the Mediterranean region.
Fuselli S; Dupanloup I; Frigato E; Cruciani F; Scozzari R; Moral P; Sistonen J; Sajantila A; Barbujani G
Eur J Hum Genet; 2004 Nov; 12(11):916-24. PubMed ID: 15340360
[TBL] [Abstract][Full Text] [Related]
7. A spatial probit model for fine-scale mapping of disease genes.
De Iorio M; Verzilli CJ
Genet Epidemiol; 2007 Apr; 31(3):252-60. PubMed ID: 17266116
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms and phenotypic analysis of cytochrome P450 2D6 in the Tibetan population.
Jin TB; Ma LF; Zhang JY; Yuan DY; Sun Q; Zong TY; Geng TT; Cui YL; Kang LL; Chen C
Gene; 2013 Sep; 527(1):360-5. PubMed ID: 23644254
[TBL] [Abstract][Full Text] [Related]
9. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use.
Dorado P; Cáceres MC; Pozo-Guisado E; Wong ML; Licinio J; Llerena A
Biotechniques; 2005 Oct; 39(4):571-4. PubMed ID: 16235570
[TBL] [Abstract][Full Text] [Related]
10. Direct analysis of unphased SNP genotype data in population-based association studies via Bayesian partition modelling of haplotypes.
Morris AP
Genet Epidemiol; 2005 Sep; 29(2):91-107. PubMed ID: 15940704
[TBL] [Abstract][Full Text] [Related]
11. Tag SNP selection for association studies.
Stram DO
Genet Epidemiol; 2004 Dec; 27(4):365-74. PubMed ID: 15372618
[TBL] [Abstract][Full Text] [Related]
12. Association studies under general disease models.
Nielsen DM; Weir BS
Theor Popul Biol; 2001 Nov; 60(3):253-63. PubMed ID: 11855959
[TBL] [Abstract][Full Text] [Related]
13. Assessment and implications of linkage disequilibrium in genome-wide single-nucleotide polymorphism and microsatellite panels.
Goode EL; Jarvik GP
Genet Epidemiol; 2005; 29 Suppl 1():S72-6. PubMed ID: 16342185
[TBL] [Abstract][Full Text] [Related]
14. CYP2D6 genotype and phenotype in Amerindians of Tepehuano origin and Mestizos of Durango, Mexico.
Sosa-Macías M; Elizondo G; Flores-Pérez C; Flores-Pérez J; Bradley-Alvarez F; Alanis-Bañuelos RE; Lares-Asseff I
J Clin Pharmacol; 2006 May; 46(5):527-36. PubMed ID: 16638736
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive survey of common genetic variation at the plasminogen activator inhibitor-1 locus and relations to circulating plasminogen activator inhibitor-1 levels.
Kathiresan S; Gabriel SB; Yang Q; Lochner AL; Larson MG; Levy D; Tofler GH; Hirschhorn JN; O'Donnell CJ
Circulation; 2005 Sep; 112(12):1728-35. PubMed ID: 16172282
[TBL] [Abstract][Full Text] [Related]
16. A first-generation linkage disequilibrium map of human chromosome 22.
Dawson E; Abecasis GR; Bumpstead S; Chen Y; Hunt S; Beare DM; Pabial J; Dibling T; Tinsley E; Kirby S; Carter D; Papaspyridonos M; Livingstone S; Ganske R; Lõhmussaar E; Zernant J; Tõnisson N; Remm M; Mägi R; Puurand T; Vilo J; Kurg A; Rice K; Deloukas P; Mott R; Metspalu A; Bentley DR; Cardon LR; Dunham I
Nature; 2002 Aug; 418(6897):544-8. PubMed ID: 12110843
[TBL] [Abstract][Full Text] [Related]
17. The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction.
Rebsamen MC; Desmeules J; Daali Y; Chiappe A; Diemand A; Rey C; Chabert J; Dayer P; Hochstrasser D; Rossier MF
Pharmacogenomics J; 2009 Feb; 9(1):34-41. PubMed ID: 18591960
[TBL] [Abstract][Full Text] [Related]
18. Frequency of single nucleotide polymorphisms of CYP2D6 in the Czech population.
Buzková H; Pechandová K; Slanar O; Perlík F
Cell Biochem Funct; 2008; 26(1):76-81. PubMed ID: 17311358
[TBL] [Abstract][Full Text] [Related]
19. Bayesian method for gene detection and mapping, using a case and control design and DNA pooling.
Johnson T
Biostatistics; 2007 Jul; 8(3):546-65. PubMed ID: 16984977
[TBL] [Abstract][Full Text] [Related]
20. Strategies to find new genes involved in drug metabolism.
Sheffield LJ
Curr Opin Mol Ther; 2001 Dec; 3(6):579-84. PubMed ID: 11804272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
